August 12th 2025
Your daily dose of the clinical news you may have missed.
August 11th 2025
FDA accepts priority review of gepotidacin for uncomplicated urogenital gonorrhea, with phase 3 data showing non-inferiority to standard injectable therapy.
July 25th 2025
Nirsevimab lowered the risk of RSV-related illness by over 87% and hospitalizations by 98% in a new study.
July 24th 2025
Vaccination lowered influenza cases by about 33% to 42% in seasonal flu setups with 40% vaccine effectiveness, researchers reported.
July 17th 2025
Merck has launched phase 3 trials for MK-8527, a promising once-monthly HIV prevention pill, aiming to enhance PrEP options globally.
FDA Greenlights Mixing COVID-19 Boosters and Moderna, J&J Booster Shots
CDC vaccine advisors will meet Thursday to discuss final approval of booster doses of Moderna and J&J vaccines and mix-and-match approach authorized by FDA.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 20, 2021
Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 19, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 18, 2021
A Drive-through Flu Shot Clinic: Is it Time to Try One?
The traditional flu shot clinic with waiting rooms full won't work this year. One practice planned its own drive-through flu vaccination clinic. Here's how.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 15, 2021
FDA Advisory Panel Supports Moderna, J&J COVID Boosters in Back-to-Back Votes
The Vaccines and Related Biological Products Advisory Committee unanimously recommended the Moderna booster on Thurday, the J&J booster on Friday.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 14, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 13, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 8, 2021
AstraZeneca Submits Request for EUA for COVID-19 Prophylaxis, AZD7442
This week, AstraZeneca submitted a request to the FDA for an emergency use authorization for their long-acting antibody cocktail for prophylaxis of COVID-19.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 7, 2021
WHO Makes Historic Recommendation for Distribution of Malaria Vaccine
WHO endorsement for widespread use in Africa of the only vaccine against malaria comes at a time when progress in control of the disease has "stalled," the organization says.
Two-dose Pfizer Vaccine Protects Against COVID-19 Hospitalization for at Least 6 Months
Two doses of the Pfizer COVID-19 vaccine also showed sustained efficacy of 93% against Delta-related hospital admission.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 6, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 5, 2021
Janssen RSV Vaccine for Older Adults Drives Robust Cellular Immune, Humoral Response
Janssen's investigational vaccine showed efficacy of up to 80% in preventing RSV-mediated lower respiratory tract infections in older adults.
COVID-19 Lockdown Had Significant, Yet Varying, Impact on Glycemic Control
EASD 2021: First analysis of its kind found COVID-19-induced lockdown was associated with improved glycemic control among patients with T1D, but not T2D.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 4, 2021
The number of US confirmed deaths has surpassed 702 000. Plus more data on the Delta variant, cases, mortalities, and vaccination in our daily update.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of October 1, 2021
Merck Oral Antiviral Reduces by Half the Risk of COVID-19 Hospitalization, Death in Vulnerable Adults
The positive results of the Merck MOVe-OUT phase 3 interim analysis of molnupiravir have led to an early halt to study recruitment, the company said Friday.
People Living with HIV Use Fewer Essential Clinical Services and Less Frequently During Pandemic
Viral-load monitoring rates decreased and clinic visits declined overall despite an increase in use of telehealth.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 30, 2021
Health Care Workers Likely to Recommend COVID-19 Vaccine to Patients Based on Safety Messaging, Survey Finds
Survey authors said findings merit further research into how to increase health care workers' confidence in discussing and recommending COVID-19 vaccines with patients.
Obesity May Put Children Hospitalized with COVID-19 at Higher Risk for Severe Disease, Suggests New Study
IDWeek 2021: Obesity prevention and vaccination efforts may help prevent COVID-19-related morbidity in pediatric COVID-19 patients with obesity, noted authors of a new study.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 29, 2021
Low Prevalence of COVID-19 and Flu Coinfection Found in Real-world Cohort Study
Coinfection with influenza virus among COVID-19 patients was found to be rare in a new study presented at IDWeek 2021.
IDWeek 2021: C diff Clinical Outcomes Unchanged after 2017 IDSA Guideline Update
IDWeek 2021: Use of vancomycin vs metronidazole increased after the 2017 IDSA recommendation but CDI recurrence rates increased slightly, investigators report.
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 28, 2021
HCV Cure is Possible in Young Drug Users, Suggests New Research Being Presented at IDWeek 2021
IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.